Doxazosin

BreastfeedingGeriatricPediatric
  • TRADE NAMES: Alfadil; Cardoxan; Cardular; Cardura (Pfizer); Dedralen; Diblocin; Supressin
  • INDICATIONS: Hypertension
  • CLASS: Adrenergic alpha-receptor antagonist
  • HALF-LIFE: 19–22 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Tadalafil, Vardenafil, Zuclopenthixol

PREGNANCY CATEGORY: C

Our database has 45 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
ENDOCRINE/METABOLIC
GENITOURINARY
OCULAR


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric